FFA
ALLO icon

Farther Finance Advisors’s Allogene Therapeutics ALLO Stock Holding History

Farther Finance Advisors’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.1K Buy
1,601
+821
+105% +$1.65K ﹤0.01% 4591
2025
Q4 		$1.07K Buy
780
+620
+388% +$818 ﹤0.01% 4892
2025
Q3 		$198 Hold
160
– – ﹤0.01% 4717
2025
Q2 		$181 Hold
160
– – ﹤0.01% 4225
2025
Q1 		$219 Hold
160
– – ﹤0.01% 3937
2024
Q4 		$341 Hold
160
– – ﹤0.01% 3523
2024
Q3 		$448 Hold
160
– – ﹤0.01% 3456
2024
Q2 		$373 Sell
160
-102
-39% -$301 ﹤0.01% 3340
2024
Q1 		$1.15K Sell
262
-56
-18% -$234 ﹤0.01% 2713
2023
Q4 		$1.02K Buy
+318
New +$902 ﹤0.01% 2722

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return